Haemonetics (HAE) Q3 Earnings Beat Estimates Posted byZacks Equity Research February 8, 2022 Leave a comment on Haemonetics (HAE) Q3 Earnings Beat Estimates Haemonetics (HAE) delivered earnings and revenue surprises of 12% and 2.58%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?